Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

가와사키병 환자의 혈청 interleukin-6, tumor necrosis factor-α, Adiponectin 치에 대한 연구

Serum interleukin-6, tumor necrosis factor-α and adiponectin levels in Kawasaki disease

  • 안정 (이화여자대학교 의과전문대학원 소아과학교실) ;
  • 김한규 (이화여자대학교 의과전문대학원 소아과학교실) ;
  • 손세정 (이화여자대학교 의과전문대학원 소아과학교실) ;
  • 홍영미 (이화여자대학교 의과전문대학원 소아과학교실)
  • An, Jung (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Kim, Han Gyu (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Sohn, Sejung (Department of Pediatrics, Ewha Womans University, School of Medicine) ;
  • Hong, Young Mi (Department of Pediatrics, Ewha Womans University, School of Medicine)
  • 투고 : 2009.06.10
  • 심사 : 2009.10.21
  • 발행 : 2010.01.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 아디포넥틴은 혈관벽의 염증 반응을 억제시켜 혈관의 remodeling을 조절하는 내인적 조절 인자이다. 그러나 가와사키병에서 아디포넥틴의 역할은 알려져 있지 않다. 이 연구의 목적은 혈중 아디포넥틴 농도와 IL-6, $TNF-{\alpha}$, lipid profile, C 반응 단백 등 몇몇 parameter들의 상관 관계를 알아보고, 아디포넥틴과 심기능의 연관성을 밝히는 것이다. 방 법 : 실험군은 가와사키병으로 진단받은 총 22명의 환아(급성기 22명, 아급성기 환아 20명)를 대상으로 하였고, 대조군은 총 31명(열성 질환이 있는 환아 13명, 건강아 18명)을 대상으로 하였다. 두 군 모두에서 혈액 검사와 TDI를 실시하였다. 결 과 : C 반응 단백은 대조군에 비해 가와사키 군에서 유의하게 증가되었다. 아디포넥틴, IL-6, $TNF-{\alpha}$ 치는 두 군 간에 유의한 차이가 없었다. 하지만 아디포넥틴과 C 반응 단백, 혈소판 수치 사이에 유의한 음의 상관 관계가 있었다. TDI로 측정한 수축기 심근 속도와 A 심근 속도가 급성기에서 아급성기, 대조군에 비해 유의하게 심근 속도가 감소됨이 확인되었고, 아디포넥틴과는 양의 상관 관계를 보였다. 결 론 : 급성 가와사키 환아에서 혈중 아디포넥틴 농도가 낮을수록 염증 반응이 심하며 좌심실의 기능이 떨어짐을 확인할 수 있었다.

Purpose : Adiponectin is an endogenous modulator of vascular remodeling that suppresses vascular inflammation. However, the role of adiponectin in Kawasaki disease (KD) has not been elucidated. The purpose of this study is to investigate the correlation between serum adiponectin level and several parameters, such as interleukin (IL)-6, tumor necrosis factor $(TNF)-{\alpha}$, lipid profile, and C reactive protein (CRP), and to clarify the association between adiponectin and cardiac function. Methods : Twenty-two KD patients (22 patients in acute phase and 20 patients in subacute phase) were enrolled in the study group. The control group consisted of 31 subjects (13 febrile patients and 18 healthy children). Both groups underwent blood sampling and tissue Doppler imaging (TDI). Results : CRP was significantly increased in the KD group compared with the control group. There were no significant differences in serum $TNF-{\alpha}$, IL-6, and adiponectin levels between groups. However, a negative correlation was found between adiponectin level and CRP level or platelet count. Systolic myocardial velocity and A myocardial velocity measured by TDI were decreased significantly in the acute KD group compared with the subacute KD group and control group. Positive correlations were found between adiponectin level and systolic myocardial velocity or A myocardial velocity. Conclusion : In acute KD patients, low adiponectin level was related to severe inflammatory reactions and decreased left ventricular functions.

키워드

참고문헌

  1. Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 2003;142:149-54 https://doi.org/10.1067/mpd.2003.46
  2. Ogawa S, Ohkubo T, Fukazawa R, Kamisago M, Kuramochi Y, Uchikoba Y, et al. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol 2004;43:653-61 https://doi.org/10.1016/j.jacc.2003.10.032
  3. Hauser M, Bengel F, Kuehn A, Nekolla S, Kaemmerer H, Schwaiger M, et al. Myocardial blood flow and coronary flow reserve in children with normal epicardial coronary arteries after the onset of Kawasaki disease assessed by positron emission tomography. Pediatr Cardiol 2004;25:108-12 https://doi.org/10.1007/s00246-003-0472-9
  4. Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease. Acta Pediatr 2006;95:1312-4 https://doi.org/10.1080/08035250600609799
  5. Masuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-91 https://doi.org/10.1074/jbc.M206083200
  6. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J Biol Chem 2002;278:2641-8
  7. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002;10:1104-10 https://doi.org/10.1038/oby.2002.150
  8. Yamauchi T, Kamon J, Waki H, Terauchi t, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6 https://doi.org/10.1038/90984
  9. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan. Pediatrics 1974;54:271-6
  10. Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1,100 cases. Pediatr Cardiol 1986;7:3-9 https://doi.org/10.1007/BF02315475
  11. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10-to 21- year follow-up study of 594 patients. Circulation 1996;94:1379-85
  12. Newburger JW, Burns JC. Kawasaki disease. Vascular Med 1999;4:187-202 https://doi.org/10.1177/1358836X9900400310
  13. Burn JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki Disease: A Brief History. Pediatrics 2000;106:e27 https://doi.org/10.1542/peds.106.2.e27
  14. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-8 https://doi.org/10.1016/0140-6736(93)92752-F
  15. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-6 https://doi.org/10.1097/00041433-200312000-00003
  16. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-49 https://doi.org/10.1161/01.RES.0000163635.62927.34
  17. Okamoto Y, Arita Y, Nishida M, Maraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheares to injured vascular walls. Horm Metab Res 2000;32:47-50 https://doi.org/10.1055/s-2007-978586
  18. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003;42:231-4 https://doi.org/10.1161/01.HYP.0000083488.67550.B8
  19. Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation 2004;109:1127-33 https://doi.org/10.1161/01.CIR.0000118501.44474.83
  20. Keller P, Moller K, Krabbe KS, Pedersen BK. Circulating adiponectin levels during human endotoxaemia. Clin Exp Immunol 2003;134:107-10 https://doi.org/10.1046/j.1365-2249.2003.02264.x
  21. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-44 https://doi.org/10.1016/S0140-6736(04)16814-1
  22. Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumor necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 1992;151:44-7 https://doi.org/10.1007/BF02073890
  23. Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90 https://doi.org/10.1136/adc.86.4.286
  24. Donovan CL, Armstrong WF, Bach DS. Quantitatve doppler tissue imaging of the left ventricular myocardium: Validation in normal subjects. Am Heart J 1995;130:100-4 https://doi.org/10.1016/0002-8703(95)90242-2
  25. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: Noninvasive technique for evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80 https://doi.org/10.1016/S0735-1097(97)88335-0
  26. Xu WJ, Gao Z, Li QS, Li CR, Zhao CY. Non-dilated coronary artery lesion and myocardial perfusion in children with Kawasaki disease: analysis of 43 cases. Zhonghua Er Ke Za Zhi 2004;42:613-6
  27. Takeuchi D, Saji T, Takatsuki S, Fufwara M. Abnormal tissue doppler images are associated with elevated plasma brain nariuretic peptide and increased oxidatve stress in acute Kawasaki disease. Circ J 2007;71:357-62 https://doi.org/10.1253/circj.71.357
  28. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007;42:1065-74 https://doi.org/10.1016/j.yjmcc.2007.03.808
  29. Cavusoglu E, Chopra V, Battala V, Ruwende C, Yanamadala S, Eng C, et al. Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patient referred for coronary angiograpy. Am J Cardiol 2008;101:1073-8 https://doi.org/10.1016/j.amjcard.2007.12.008